Mesenchymal Stromal Cells as a Driver of Inflammaging
International Journal of Molecular Sciences · 28.03.2023 · 24 (7) · 6372
DOI: 10.3390/ijms24076372 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2023. Verfasst von Svetlana Lyamina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pathology of Digestion Laboratory, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Delegatskaya Str., 20/1, 127473 Mosco…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Life expectancy and age-related diseases burden increased significantly over the past few decades. Age-related conditions are commonly discussed in a very limited paradigm of depleted cellular proliferation and maturation with exponential accumulation of senescent cells. However, most recent evidence showed that the majority of age-associated ailments, i.e., diabetes mellitus, cardiovascular diseases and neurodegeneration. These diseases are closely associated with tissue nonspecific inflammation triggered and controlled by mesenchymal stromal cell secretion. Mesenchymal stromal cells (MSCs) are known as the most common type of cells for therapeutic approaches in clinical practice. Side effects and complications of MSC-based treatments increased interest in the MSCs secretome as an alternative concept for validation tests in regenerative medicine. The most recent data also proposed it as an ideal tool for cell-free regenerative therapy and tissue engineering. However, senescent MSCs secretome was shown to hold the role of ‘key-driver’ in inflammaging. We aimed to review the immunomodulatory effects of the MSCs-secretome during cell senescence and provide eventual insight into the interpretation of its beneficial biological actions in inflammaging-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Pathology of Digestion Laboratory, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Delegatskaya Str., 20/1, 127473 Moscow, Russia.
- Scientific Research Institute for Systems Biology and Medicine, Nauchniy Proezd, 18, 117246 Moscow, Russia.
- Research and Educational Resource Center for Cellular Technologies, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.
- National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 249036 Obninsk, Russia.
ORCID-Profile: Denis Baranovskii, Ilya Klabukov
Zitieren
APA
Lyamina, S., Baranovskii, D., Kozhevnikova, E., Ivanova, T., Kalish, S., Sadekov, T., Klabukov, I., Maev, I., & Govorun, V. (2023). Mesenchymal Stromal Cells as a Driver of Inflammaging. International Journal of Molecular Sciences, 24(7), 6372. https://doi.org/10.3390/ijms24076372
Vancouver
Lyamina S, Baranovskii D, Kozhevnikova E, Ivanova T, Kalish S, Sadekov T, et al. Mesenchymal Stromal Cells as a Driver of Inflammaging. International Journal of Molecular Sciences. 2023;24(7):6372. doi:10.3390/ijms24076372
BibTeX
@article{Lyamina2023,
author = {Lyamina, Svetlana and Baranovskii, Denis and Kozhevnikova, Ekaterina and Ivanova, Tatiana and Kalish, Sergey and Sadekov, Timur and Klabukov, Ilya and Maev, Igor and Govorun, Vadim},
title = {Mesenchymal Stromal Cells as a Driver of Inflammaging},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6372},
doi = {10.3390/ijms24076372}
}
EUVIMED